ReviewCancer biology & therapy2019

Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses.

Ilyas Sahin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.